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Background
HIV-1 hijacks cellular machineries to replicate. Post-
translational modifications, like acetylation, phosphoryla-
tion or ubiquitination are not exception. We are inter-
ested in studying the interplay between HIV-1 and the
SUMOylation pathway.
SUMOylation consists in the covalent attachment of
SUMO (Small Ubiquitin-like Modifier) proteins to a lysine
residue of a target protein, often found within a consensus
motif (ΨKxD/E, where Ψ is a hydrophobic residue, x is any
amino acid, D or E is an acidic residue). SUMO proteins
share structural similarities with ubiquitin, and are conju-
gated to the substrate by an analogous but distinct enzy-
matic cascade requiring the sequential action of E1
activating enzyme (SAE1/SAE2 heterodimer), E2 conjugat-
ing enzyme (Ubc9), and E3 ligases. So far, several E3
SUMO ligases have been characterized, such as nuclear
pore complex component Ran-binding protein 2
(RanBP2), protein-inhibitor of activated STAT (PIAS)
family proteins, etc. Despite that Ubc9 can directly transfer
SUMO moieties to acceptor lysine residues, E3 SUMO
ligases promote specificity and/or efficiency of SUMO con-
jugation. We have recently shown that HIV-1 integrase,
the viral enzyme that is responsible for viral genome inte-
gration into host cellular chromosome, is SUMOylated.
Virions harboring a SUMOylation-defective integrase are
less infectious than WT HIV-1, indicating that this modifi-
cation is important for efficient viral replication [1].
Materials and methods and results
To better characterize the involvement of SUMOylation
during HIV-1 replication, we addressed the role of E3
SUMO ligases in the conjugation of SUMO to integrase.
By immunoprecipitation and GST pull-down approaches,
we establish that HIV-1 integrase interacts with a PIAS
family member protein, PIAS3. By immunofluorescence
and confocal microscopy, we show that integrase and
PIAS3 colocalise. Moreover, by Ni
2+ pull-down in denatur-
ing conditions, we demonstrate that PIAS3 increases inte-
grase SUMOylation. We also analyzed the effect of PIAS3
over-expression in virus-producing or target cells and did
not find a significant variation of viral infectivity.
Conclusions
We find that one of the proteins of the PIAS family,
PIAS3, interacts with HIV-1 integrase and increases its
SUMOylation.
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